Cargando…
Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy
The current COVID-19 global pandemic poses immense challenges to global health, largely due to the difficulty to detect infection in the early stages of the disease, as well as the current lack of effective antiviral therapy. Research and understanding of the human immune system can provide importan...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760112/ https://www.ncbi.nlm.nih.gov/pubmed/35031959 http://dx.doi.org/10.1007/s12016-021-08912-y |
_version_ | 1784633250473312256 |
---|---|
author | Cheng, Zhangkai J. Li, Bizhou Zhan, Zhiqing Zhao, Zifan Xue, Mingshan Zheng, Peiyan Lyu, Jiali Hu, Chundi He, Jianxing Chen, Ruchong Sun, Baoqing |
author_facet | Cheng, Zhangkai J. Li, Bizhou Zhan, Zhiqing Zhao, Zifan Xue, Mingshan Zheng, Peiyan Lyu, Jiali Hu, Chundi He, Jianxing Chen, Ruchong Sun, Baoqing |
author_sort | Cheng, Zhangkai J. |
collection | PubMed |
description | The current COVID-19 global pandemic poses immense challenges to global health, largely due to the difficulty to detect infection in the early stages of the disease, as well as the current lack of effective antiviral therapy. Research and understanding of the human immune system can provide important theoretical and technical support for the clinical diagnosis and treatment of COVID-19, the clinical implementations of which include immunoassays and immunotherapy, which play a crucial role in the fight against the pandemic. This review consolidates the current scientific evidence for immunoassay, which includes multiple methods of detecting antigen and antibody against SARS-CoV-2. We compared the characteristics, advantages and disadvantages, and clinical applications of these three detection techniques. In addition to detecting viral infections, knowledge on the body’s immunity against the virus is desirable; thus, the immunotherapy-based neutralizing antibody (nAb) detection methods were discussed. We also gave a brief introduction to the new immunoassay technology such as biosensing. This was followed by an in-depth and extensive review on a variety of immunotherapy methods. It includes convalescent plasma therapy, neutralizing antibody–based treatments targeting different regions of SARS-CoV-2, immunotherapy targeted on the host cell including inhibiting the host cell receptor and cytokine storm, as well as cocktail antibodies, cross-neutralizing antibodies, and immunotherapy based on cross-reactivity between viral epitopes and autoepitopes and autoantibody. Despite the development of various immunological testing methods and antibody therapies, the current global situation of COVID-19 is still tense. We need more efficient detection methods and more reliable antibody therapies. The up-to-date knowledge on therapeutic strategies will likely help clinicians worldwide to protect patients from life-threatening viral infections. |
format | Online Article Text |
id | pubmed-8760112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-87601122022-01-18 Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy Cheng, Zhangkai J. Li, Bizhou Zhan, Zhiqing Zhao, Zifan Xue, Mingshan Zheng, Peiyan Lyu, Jiali Hu, Chundi He, Jianxing Chen, Ruchong Sun, Baoqing Clin Rev Allergy Immunol Article The current COVID-19 global pandemic poses immense challenges to global health, largely due to the difficulty to detect infection in the early stages of the disease, as well as the current lack of effective antiviral therapy. Research and understanding of the human immune system can provide important theoretical and technical support for the clinical diagnosis and treatment of COVID-19, the clinical implementations of which include immunoassays and immunotherapy, which play a crucial role in the fight against the pandemic. This review consolidates the current scientific evidence for immunoassay, which includes multiple methods of detecting antigen and antibody against SARS-CoV-2. We compared the characteristics, advantages and disadvantages, and clinical applications of these three detection techniques. In addition to detecting viral infections, knowledge on the body’s immunity against the virus is desirable; thus, the immunotherapy-based neutralizing antibody (nAb) detection methods were discussed. We also gave a brief introduction to the new immunoassay technology such as biosensing. This was followed by an in-depth and extensive review on a variety of immunotherapy methods. It includes convalescent plasma therapy, neutralizing antibody–based treatments targeting different regions of SARS-CoV-2, immunotherapy targeted on the host cell including inhibiting the host cell receptor and cytokine storm, as well as cocktail antibodies, cross-neutralizing antibodies, and immunotherapy based on cross-reactivity between viral epitopes and autoepitopes and autoantibody. Despite the development of various immunological testing methods and antibody therapies, the current global situation of COVID-19 is still tense. We need more efficient detection methods and more reliable antibody therapies. The up-to-date knowledge on therapeutic strategies will likely help clinicians worldwide to protect patients from life-threatening viral infections. Springer US 2022-01-15 2023 /pmc/articles/PMC8760112/ /pubmed/35031959 http://dx.doi.org/10.1007/s12016-021-08912-y Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Cheng, Zhangkai J. Li, Bizhou Zhan, Zhiqing Zhao, Zifan Xue, Mingshan Zheng, Peiyan Lyu, Jiali Hu, Chundi He, Jianxing Chen, Ruchong Sun, Baoqing Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy |
title | Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy |
title_full | Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy |
title_fullStr | Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy |
title_full_unstemmed | Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy |
title_short | Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy |
title_sort | clinical application of antibody immunity against sars-cov-2: comprehensive review on immunoassay and immunotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760112/ https://www.ncbi.nlm.nih.gov/pubmed/35031959 http://dx.doi.org/10.1007/s12016-021-08912-y |
work_keys_str_mv | AT chengzhangkaij clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy AT libizhou clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy AT zhanzhiqing clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy AT zhaozifan clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy AT xuemingshan clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy AT zhengpeiyan clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy AT lyujiali clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy AT huchundi clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy AT hejianxing clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy AT chenruchong clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy AT sunbaoqing clinicalapplicationofantibodyimmunityagainstsarscov2comprehensivereviewonimmunoassayandimmunotherapy |